Mike Polark
Stock Analyst at Wolfe Research
(3.09)
# 1,221
Out of 5,139 analysts
84
Total ratings
44.64%
Success rate
3.04%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Outperform | $47 | $44.12 | +6.53% | 1 | Jan 12, 2026 | |
| IRTC iRhythm Holdings | Maintains: Outperform | $235 → $220 | $167.16 | +31.61% | 13 | Dec 16, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $125 → $180 | $92.23 | +95.16% | 9 | Dec 4, 2025 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $84.35 | - | 5 | Oct 29, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $96.76 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $18.50 | +8.11% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $62.11 | -3.40% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $287.70 | +21.65% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $22.85 | +26.91% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $257.58 | -30.12% | 5 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $87.31 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $363.78 | +11.33% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $535.00 | -5.98% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $121.76 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $103.00 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $69.54 | +74.00% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $20.16 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $19.18 | +30.34% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $142.06 | +16.15% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $88.07 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $16.94 | -23.26% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $5.01 | +319.16% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $268.65 | -6.94% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $2.08 | +1,967.31% | 1 | Sep 2, 2020 |
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $44.12
Upside: +6.53%
iRhythm Holdings
Dec 16, 2025
Maintains: Outperform
Price Target: $235 → $220
Current: $167.16
Upside: +31.61%
Inspire Medical Systems
Dec 4, 2025
Maintains: Outperform
Price Target: $125 → $180
Current: $92.23
Upside: +95.16%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $84.35
Upside: -
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $96.76
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $18.50
Upside: +8.11%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $62.11
Upside: -3.40%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $287.70
Upside: +21.65%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $22.85
Upside: +26.91%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $257.58
Upside: -30.12%
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $87.31
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $363.78
Upside: +11.33%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $535.00
Upside: -5.98%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $121.76
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $103.00
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $69.54
Upside: +74.00%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $20.16
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $19.18
Upside: +30.34%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $142.06
Upside: +16.15%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $88.07
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $16.94
Upside: -23.26%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $5.01
Upside: +319.16%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $268.65
Upside: -6.94%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $2.08
Upside: +1,967.31%